CHICAGO TRUST Co NA Sells 6,400 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

CHICAGO TRUST Co NA lowered its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 22.3% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 22,278 shares of the pharmacy operator’s stock after selling 6,400 shares during the quarter. CHICAGO TRUST Co NA’s holdings in Walgreens Boots Alliance were worth $208,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of the business. State Street Corp boosted its position in Walgreens Boots Alliance by 18.0% during the 3rd quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator’s stock valued at $385,258,000 after acquiring an additional 6,569,223 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its position in Walgreens Boots Alliance by 43.6% during the third quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator’s stock valued at $98,284,000 after purchasing an additional 3,329,857 shares in the last quarter. Two Sigma Advisers LP purchased a new position in Walgreens Boots Alliance in the third quarter valued at about $24,226,000. Newport Trust Company LLC purchased a new position in Walgreens Boots Alliance in the second quarter valued at about $31,028,000. Finally, Thompson Siegel & Walmsley LLC raised its holdings in Walgreens Boots Alliance by 15.5% in the third quarter. Thompson Siegel & Walmsley LLC now owns 6,955,880 shares of the pharmacy operator’s stock worth $62,325,000 after purchasing an additional 934,754 shares in the last quarter. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Performance

Shares of NASDAQ WBA opened at $11.90 on Tuesday. The stock has a market cap of $10.28 billion, a price-to-earnings ratio of -1.19, a PEG ratio of 1.36 and a beta of 0.64. Walgreens Boots Alliance, Inc. has a 12 month low of $8.08 and a 12 month high of $23.76. The company has a 50 day simple moving average of $9.31 and a two-hundred day simple moving average of $9.81. The company has a current ratio of 0.68, a quick ratio of 0.37 and a debt-to-equity ratio of 0.67.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, topping the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The business had revenue of $39.50 billion for the quarter, compared to analyst estimates of $37.40 billion. During the same quarter in the prior year, the firm posted $0.66 EPS. The business’s quarterly revenue was up 7.6% compared to the same quarter last year. As a group, analysts predict that Walgreens Boots Alliance, Inc. will post 1.53 earnings per share for the current year.

Walgreens Boots Alliance Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, December 12th. Investors of record on Monday, November 18th were issued a $0.25 dividend. The ex-dividend date was Monday, November 18th. This represents a $1.00 annualized dividend and a dividend yield of 8.40%. Walgreens Boots Alliance’s dividend payout ratio is presently -9.77%.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on WBA. Truist Financial cut their price objective on shares of Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating on the stock in a research report on Monday, October 7th. TD Cowen cut their price target on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a report on Tuesday, October 22nd. Royal Bank of Canada decreased their price objective on Walgreens Boots Alliance from $13.00 to $9.00 and set a “sector perform” rating for the company in a report on Wednesday, December 4th. Evercore ISI boosted their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research note on Monday. Finally, Bank of America upped their target price on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a research report on Monday. Four investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $12.81.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.